Sanofi (SNY) Research & Development (2016 - 2025)
Historic Research & Development for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$9.1 billion.
- Sanofi's Research & Development fell 1554.28% to -$9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$19.7 billion, marking a year-over-year decrease of 4592.41%. This contributed to the annual value of -$8.9 billion for FY2025, which is 1073.94% down from last year.
- Per Sanofi's latest filing, its Research & Development stood at -$9.1 billion for Q4 2025, which was down 1554.28% from -$6.5 billion recorded in Q3 2025.
- In the past 5 years, Sanofi's Research & Development ranged from a high of -$1.5 billion in Q1 2021 and a low of -$9.1 billion during Q4 2025
- In the last 5 years, Sanofi's Research & Development had a median value of -$1.8 billion in 2021 and averaged -$3.2 billion.
- Its Research & Development has fluctuated over the past 5 years, first tumbled by 754204.2% in 2021, then crashed by 32.6% in 2023.
- Sanofi's Research & Development (Quarter) stood at -$1.8 billion in 2021, then crashed by 277.33% to -$6.8 billion in 2022, then fell by 2.33% to -$7.0 billion in 2023, then dropped by 12.86% to -$7.9 billion in 2024, then decreased by 15.54% to -$9.1 billion in 2025.
- Its last three reported values are -$9.1 billion in Q4 2025, -$6.5 billion for Q3 2025, and -$2.2 billion during Q2 2025.